Month: April 2018

Lexington Releases Audited Consolidated Financial Statements

VANCOUVER, British Columbia, April 30, 2018 — Lexington Biosciences, Inc. (CSE:LNB) (OTCQB:LXGTF) (the “Company” or “Lexington”), a development-stage medical device company, has released its audited Consolidated Financial Statements and Management, Discussion and Analysis for the year ended December 31, 2017, both of which are available for review via the Company’s website at; or via SEDAR at Overall

Read More



Newsletter Updates

If you haven’t already done so, signup here to receive future editions and the latest company news direct to your inbox.

Latest News